(AMD) Borrelia burgdorferi qPCR detection kit CE-IVD

CE-IVD marked qPCR kits for molecular diagnostics in oncology, infection detection, antimicrobial resistance, and genetic testing. Kits include all reagents with internal controls and are validated on multiple real-time PCR platforms. Assays designed to CDC and WHO standards offer high sensitivity and specificity with simplified setup and data analysis.

Regulatory-approved reverse transcription PCR kit meeting European In Vitro Diagnostic requirements. Suitable for clinical diagnostic applications in regulated markets.

Real-time PCR kit for detection and identification of Borrelia burgdorferi, the causative agent of Lyme disease. The singleplex assay includes RNase P internal control for sample validation. CE IVDR-marked and ISO 13485-certified for clinical laboratory use.

Sensitive and fast dPCR-based assay for detecting key sepsis-causing pathogens, enabling clinicians to make timely diagnostic decisions. CE-IVD certified for clinical use.

CE-IVD certified digital PCR assay for rapid detection of key sepsis-causing pathogens including bacteria and fungi. Enables timely clinical decision-making in intensive care and emergency settings.

CE-IVD certified dPCR assay for sensitive and rapid detection of key sepsis-causing pathogens, enabling timely clinical decision-making in critical care settings.

CE-IVD approved rapid reverse transcription PCR kit for detecting viral RNA in clinical samples. Provides accelerated results for infectious disease diagnosis.

A diagnostic test for detecting Borrelia burgdorferi, the causative agent of Lyme disease, in blood samples. This test is used in clinical laboratories for diagnosis of Lyme disease.

CE IVD real-time PCR kit for detection of HLA-B27 allele in human genomic DNA using allele-specific primers and fluorescently labeled hydrolysis probes. Designed for diagnosis of ankylosing spondylitis and related inflammatory disorders. Available with 25 or 50 reactions per kit.

A diagnostic test kit for the detection of Borrelia burgdorferi sensu lato pathogens. This product is available in multiple variants that can be selected based on specific testing requirements.

ELISA test kit for the detection of antibodies to Borrelia burgdorferi in human serum or plasma. Supports laboratory diagnosis of Lyme disease and other borreliosis infections.

A quality control reagent containing Borrelia burgdorferi DNA for molecular diagnostic assay validation. This control material is used in real-time PCR assays for diagnosis of Lyme disease infections.